Deubiquitinases in hematological malignancies
Abstract Deubiquitinases (DUBs) are enzymes that control the stability, interactions or localization of most cellular proteins by removing their ubiquitin modification. In recent years, some DUBs, such as USP7, USP9X and USP10, have been identified as promising therapeutic targets in hematological m...
Saved in:
Main Authors: | Hu Lei (Author), Jiaqi Wang (Author), Jiacheng Hu (Author), Qian Zhu (Author), Yingli Wu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting deubiquitinases for cancer therapy
by: Qian Xue, et al.
Published: (2023) -
Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis
by: Fang Qiu, et al.
Published: (2024) -
Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression
by: Meijia Qian, et al.
Published: (2021) -
Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?
by: Gloria Lopez-Castejon, et al.
Published: (2016) -
Trends in mortality from infection among patients with hematologic malignancies: differences according to hematologic malignancy subtype
by: Xuejiao Yin, et al.
Published: (2023)